Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Social Drivers of Health and Hidradenitis Suppurativa Care

Description

The talk explains how social drivers of health shape hidradenitis suppurativa (HS) and how HS can, in turn, worsen social and economic instability. It reviews major social driver categories—neighborhood conditions, housing, transportation, social support, language, insurance, and health literacy—and connects them to HS risk, disease severity, and barriers to care. Neighborhood disadvantage, walkability, food access, tobacco exposure, heat, and low socioeconomic status are linked to higher HS risk and worse outcomes, while HS-related pain, stigma, and treatment burden can reduce income, disrupt work, and threaten insurance and basic needs. The speaker offers practical clinic strategies: ask about social circumstances with clear explanations, use sensitive wording about housing, and tailor treatment plans to real-world constraints such as medication delivery, refrigeration, and homelessness. Recommendations include coordinating pharmacy pickup or nurse visits, involving social workers and patient navigators, considering medical respite for hospitalized patients, flexing appointments and transport support, connecting patients to peer support groups, using certified interpreters ideally in person, advocating for insurance coverage and eligibility support, simplifying language and written materials to a sixth-grade level, and documenting how social drivers affect management to support billing and care planning. The central message is to identify barriers, adjust care accordingly, and act as an advocate for patients with HS.

View more

Conclusions

  • Social drivers of health and hidradenitis suppurativa influence each other bidirectionally, with social conditions affecting HS risk and HS worsening economic and social stability.
  • Neighborhood disadvantage, poor walkability, unhealthy food environments, and hotter urban microclimates appear associated with higher HS burden or worse disease.
  • HS can contribute to lower income, slower income growth, unemployment, and loss of employer-sponsored insurance, creating a cycle that can worsen disease control.
  • Housing insecurity and inability to safely store or receive medications can directly interfere with biologic treatment delivery and should be actively assessed.
  • Clinicians should ask about social drivers at the point of management planning, explain why they are asking, and not rely on charted information alone.
  • Practical care changes such as alternate pharmacy delivery, nurse injection visits, cooler storage strategies, or medical respite can help patients who lack stable housing or refrigeration.
  • Transportation barriers, dependent care responsibilities, and unstable housing often require flexible scheduling, flexible visit formats, and assistance with transit resources.
  • HS-related stigma and isolation mean that offering peer support and patient connection resources may improve the lived experience of care.
  • For patients with limited English proficiency, certified bilingual interpreters are preferred, and in-person interpreters may improve nuance, rapport, and recognition of nonverbal cues.
  • Using plain language and sixth-grade-level written materials can improve recall, adherence, and decision-making in HS care.
  • Addressing social drivers should be documented as influencing management, both to support better care and to justify appropriate billing and Z-code use.
  • Overall, integrating social-driver assessment, communication adjustments, and community resource referral is presented as essential dermatologic care for HS patients.
  • Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study#10.1016/j.jaad.2016.04.067
  • Hidradenitis suppurativa and social disadvantage: A nationwide administrative data study of the French hospitalized population#10.1111/jdv.19159
  • Neighborhood-based analysis of adolescent hidradenitis suppurativa prevalence in a large metropolitan area#10.1016/j.jdin.2022.08.015
  • Chang AY, et al. JAMA Dermatol. 2025;161(7):707–714.
  • Hernandez Y, et al. JAMA Dermatol. 2026;162(2):151-156.